83 FR 16113 - National Institute on Minority Health and Health Disparities; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 72 (April 13, 2018)

Page Range		16113-16113
FR Document		2018-07756

Federal Register, Volume 83 Issue 72 (Friday, April 13, 2018)

[Federal Register Volume 83, Number 72 (Friday, April 13, 2018)]
[Notices]
[Page 16113]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-07756]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Minority Health and Health Disparities; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Minority Health and 
Health Disparities Special Emphasis Panel; Mechanisms of Disparities 
for HIV-Related Co-morbidities in Health Disparity Populations.
    Date: May 30, 2018.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Minority Health and Health 
Disparities, 7201 Wisconsin Ave., Suite 525, Rm. 533K, Bethesda, MD 
20814 (Telephone Conference Call).
    Contact Person: Xinli Nan, Ph.D., Scientific Review Officer, 
National Institute on Minority Health and Health Disparities, 
National Institutes of Health, Scientific Review Branch, OERA, 7201 
Wisconsin Ave., Suite 525, Bethesda, MD 20814, (301) 594-7784, 
Xinli.Nan@nih.gov.


    Dated: April 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07756 Filed 4-12-18; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 72 / Friday, April 13, 2018 / Notices 16113

government-issued photo ID, driver’s license, Review Branch, OERA, 7201 Wisconsin Ave., (Catalogue of Federal Domestic Assistance
or passport) and to state the purpose of their Suite 525, Bethesda, MD 20814, (301) 594– Program No.: 93.279, Drug Abuse and
visit. 7784, Xinli.Nan@nih.gov. Addiction Research Programs, National
Information is also available on the Institutes of Health, HHS)
Council of Council’s home page at http:// Dated: April 10, 2018.
Dated: April 10, 2018.
dpcpsi.nih.gov/council/ where an agenda David D. Clary,
will be posted before the meeting date. Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
(Catalogue of Federal Domestic Assistance Committee Policy. Program Analyst, Office of Federal Advisory
Program Nos. 93.14, Intramural Research Committee Policy.
[FR Doc. 2018–07756 Filed 4–12–18; 8:45 am]
Training Award; 93.22, Clinical Research [FR Doc. 2018–07754 Filed 4–12–18; 8:45 am]
BILLING CODE 4140–01–P
Loan Repayment Program for Individuals BILLING CODE 4140–01–P
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research DEPARTMENT OF HEALTH AND
HUMAN SERVICES DEPARTMENT OF HEALTH AND
Enhancement Award; 93.936, NIH Acquired
HUMAN SERVICES
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate National Institutes of Health
National Institutes of Health
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National National Institute on Drug Abuse;
Notice of Closed Meetings Center for Scientific Review; Notice of
Institutes of Health, HHS)
Closed Meetings
Dated: April 10, 2018. Pursuant to section 10(d) of the
David D. Clary, Federal Advisory Committee Act, as Pursuant to section 10(d) of the
Program Analyst, Office of Federal Advisory amended, notice is hereby given of the Federal Advisory Committee Act, as
Committee Policy. following meetings. amended, notice is hereby given of the
[FR Doc. 2018–07757 Filed 4–12–18; 8:45 am] The meetings will be closed to the following meetings.
public in accordance with the The meetings will be closed to the
BILLING CODE 4140–01–P
provisions set forth in sections public in accordance with the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provisions set forth in sections
DEPARTMENT OF HEALTH AND as amended. The contract proposals and 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
HUMAN SERVICES the discussions could disclose as amended. The grant applications and
confidential trade secrets or commercial the discussions could disclose
National Institutes of Health property such as patentable material, confidential trade secrets or commercial
and personal information concerning property such as patentable material,
National Institute on Minority Health individuals associated with the contract and personal information concerning
and Health Disparities; Notice of proposals, the disclosure of which individuals associated with the grant
Closed Meeting would constitute a clearly unwarranted applications, the disclosure of which
invasion of personal privacy. would constitute a clearly unwarranted
Pursuant to section 10(d) of the
invasion of personal privacy.
Federal Advisory Committee Act, as Name of Committee: National Institute on
amended, notice is hereby given of the Drug Abuse Special Emphasis Panel; Name of Committee: Center for Scientific
following meeting. Synthesis and Distribution of Drugs of Abuse Review Special Emphasis Panel; Chronic
The meeting will be closed to the and Related Compounds (8944). Disease in the Caribbean-II.
public in accordance with the Date: April 24, 2018. Date: April 16, 2018.
Time: 10:00 a.m. to 1:00 p.m. Time: 3:00 p.m. to 3:30 p.m.
provisions set forth in sections Agenda: To review and evaluate grant
Agenda: To review and evaluate contract
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., proposals. applications.
as amended. The grant applications and Place: National Institutes of Health, Place: National Institutes of Health, 6701
the discussions could disclose Neuroscience Center, 6001 Executive Rockledge Drive, Bethesda, MD 20892
confidential trade secrets or commercial Boulevard, Rockville, MD 20852 (Telephone (Telephone Conference Call).
property such as patentable materials, Conference Call). Contact Person: Gniesha Yvonne
and personal information concerning Contact Person: Lyle Furr, Scientific Dinwiddie, Ph.D., Scientific Review Officer,
individuals associated with the grant Review Officer, Office of Extramural Affairs, Center for Scientific Review, National
applications, the disclosure of which National Institute on Drug Abuse, NIH, Institutes of Health, 6701 Rockledge Drive,
DHHS, Room 4227, MSC 9550, 6001 Room 3137, Bethesda, MD 20892,
would constitute a clearly unwarranted Executive Boulevard, Bethesda, MD 20892– dinwiddiegy@csr.nih.gov.
invasion of personal privacy. 9550, (301) 827–5702, lf33c.nih.gov. This notice is being published less
Name of Committee: National Institute on Name of Committee: National Institute on than 15 days prior to the meeting due
Minority Health and Health Disparities Drug Abuse Special Emphasis Panel; to the timing limitations imposed by the
Special Emphasis Panel; Mechanisms of Toxicological Evaluations of Potential
Disparities for HIV-Related Co-morbidities in
review and funding cycle.
Medications to Treat Drug Addiction (8939).
Health Disparity Populations. Date: May 15, 2018. Name of Committee: Center for Scientific
Date: May 30, 2018. Time: 10:00 a.m. to 1:00 p.m. Review Special Emphasis Panel; AIDS and
Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract Related Research Special Topic.
Agenda: To review and evaluate grant proposals. Date: April 19, 2018.
applications. Place: National Institutes of Health, Time: 11:00 a.m. to 1:00 p.m.
Place: National Institute on Minority Neuroscience Center, 6001 Executive Agenda: To review and evaluate grant
daltland on DSKBBV9HB2PROD with NOTICES

Health and Health Disparities, 7201 Boulevard, Rockville, MD 20852 (Telephone applications.
Wisconsin Ave., Suite 525, Rm. 533K, Conference Call). Place: National Institutes of Health, 6701
Bethesda, MD 20814 (Telephone Conference Contact Person: Lyle Furr, Scientific Rockledge Drive, Bethesda, MD 20892
Call). Review Officer, Office of Extramural Affairs, (Telephone Conference Call).
Contact Person: Xinli Nan, Ph.D., Scientific National Institute on Drug Abuse, NIH, Contact Person: Robert Freund, Ph.D.,
Review Officer, National Institute on DHHS, Room 4227, MSC 9550, 6001 Scientific Review Officer, Center for
Minority Health and Health Disparities, Executive Boulevard, Bethesda, MD 20892– Scientific Review, National Institutes of
National Institutes of Health, Scientific 9550, (301) 827–5702, lf33c.nih.gov. Health, 6701 Rockledge Drive, Room 5216,

VerDate Sep<11>2014 19:04 Apr 12, 2018 Jkt 244001 PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 E:\FR\FM\13APN1.SGM 13APN1

Document Created: 2018-04-13 00:18:16
Document Modified: 2018-04-13 00:18:16

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		May 30, 2018.
FR Citation		83 FR 16113

83 FR 16113 - National Institute on Minority Health and Health Disparities; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 72 (April 13, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health